Outcomes following HDR Brachytherapy Boost for High Risk Localised Prostate Cancer: Data from a UK Centre

被引：0
|
作者：
Lorimer, C. [1 ]
Ravi, B. [1 ]
Cowtan, F. [1 ]
Johns, A. [1 ]
Robinson, A. [1 ]
Nikapota, A. [1 ]
机构：
[1] Univ Hosp Sussex NHS Trust, Brighton, England
来源：
CLINICAL ONCOLOGY | 2023年 / 35卷 / 02期
关键词：
DOSE-RATE BRACHYTHERAPY; INTERMEDIATE; MONOTHERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E241 / E241
页数：1
相关论文
共 50 条
  • [11] HDR brachytherapy as a boost for intermediate and high risk prostate cancer: Longterm outcome of 2028 implants
    Kurek, R
    Martin, T
    Buhleier, T
    Dannenberg, T
    Baltas, D
    Zamboglou, N
    Tunn, UW
    JOURNAL OF UROLOGY, 2006, 175 (04): : 314 - 314
  • [12] Outcomes of radical prostatectomies and HDR brachytherapy in patients with intermediate and high risk prostate cancer
    Macek, P.
    Stricker, P.
    Stevens, M.
    Jagavkar, R.
    Chalasani, V.
    Haynes, A. M.
    Matthews, J.
    Brenner, P.
    Golovsky, D.
    Kooner, R.
    O'Neill, G.
    BJU INTERNATIONAL, 2006, 97 : 3 - 3
  • [13] HDR brachytherapy boost improves metastatic free survival in high and very-high risk prostate cancer
    Visus, I.
    Barco, A.
    Obeso, J.
    Barrado, M.
    Sola, A.
    Villafranca, E.
    Fuentemilla, N.
    Pellejero, S.
    Navarrete, P.
    Martinez, E.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S536 - S537
  • [14] 17 years' of EBRT plus HDR brachytherapy boost in high risk localized prostate cancer patients
    Vigneault, E.
    Carignan, D.
    Magnan, S.
    Froment, M.
    Foster, W.
    Aubin, S.
    Lavallee, M.
    Lacroix, F.
    Cantin, A.
    Poulin, E.
    Martin, A.
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : S69 - S70
  • [15] HDR Brachytherapy in the Management of High-Risk Prostate Cancer
    Masson, Susan
    Persad, Raj
    Bahl, Amit
    ADVANCES IN UROLOGY, 2012, 2012
  • [16] A prospective randomised trial of HDR brachytherapy boost in radical radiotherapy for localised carcinoma of the prostate
    Hoskin, P.
    Ostler, P.
    Bownes, P.
    Woodruffe, M.
    Philips, H.
    Motohashi, K.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S148 - S148
  • [17] THE ROLE OF CAPRA SCORE AS A PREDICTOR OF OUTCOMES IN HIGH-RISK PROSTATE CANCER PATIENTS TREATED WITH EBRT PLUS HDR BRACHYTHERAPY BOOST
    Vigneault, Eric
    Carignan, Damien
    Magnan, Sindy
    Despres, Philippe
    Martin, Andre-Guy
    Foster, William
    Lavallee, Marie-Claude
    Aubin, Sylviane
    Lacroix, Frederic
    Froment, Marie-Anne
    Cantin, Audrey
    Poulin, Eric
    Morales, Brandon
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S65 - S65
  • [18] Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group
    Ka, Kanta
    Schiappa, Renaud
    Terlizzi, Mario
    Mallet, Frederic
    Martin, Etienne
    Chand, Marie -Eve
    Demogeot, Nicolas
    Peiffert, Didier
    Pommier, Pascal
    Quivrin, Magali
    Kissel, Manon
    Pasquier, Corentin
    Khalifa, Jonathan
    Bossi, Alberto
    Hannoun-Levi, Jean -Michel
    Blanchard, Pierre
    RADIOTHERAPY AND ONCOLOGY, 2023, 180
  • [19] Single dose high dose-rate (HDR) brachytherapy as monotherapy for localised prostate cancer
    Tharmalingam, H.
    Tsang, Y. M.
    Hoskin, P.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S337 - S337
  • [20] SBRT boost is a viable alternative to HDR brachytherapy boost for prostate cancer patients
    Grabec, D.
    Majdic, A.
    Carman, J.
    Kragelj, B.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1239 - S1240
12345